Patent · US Expired

Use of dicentrine and its derivatives for the treatment of hypertension, arrhythmia, thrombosis and atherosclerosis

US5262421A · kind A · utility

2Cited by

1References

4Claims

0Family size

Assignee

National Science Council · TW

Inventors

Ming-Jai Su · Taipei, TW
Chien-Chih Chen · Hsinchu, TW
Che-Ming Teng · Taipei, TW
Sheu-Meei Yu · Taipei, TW

Key dates

Filing date	Dec 2, 1991
Grant date	Nov 16, 1993
Priority date	—
Expiry date	Dec 2, 2011

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K36/54
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for the treatment of hypertension, arrhythmia, thrombosis or/and atherosclerosis with an effective amount of dicentrine or other alkaloids extracted from Lindera oldhammii (megaphylla) Hemsl.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.